Physician Assistant in Agana Heights, GU Accepting Medicare

3 Physician Assistant nurses found. Showing 1 - 3

Jason Robert Hannibal, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 50 Farenholt Ave, Agana Heights, GU 96913 Phone: 671-344-9340

Justin Michael Loder, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: U.s. Naval Hospital Guam, Farenholt Ave, Bldg 50, Agana Heights, GU 96910 Phone: 671-344-9315

Thomas E Williams, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Bldg #50, Farenholt Ave, Agana Heights, GU 96910 Phone: 671-339-3013

News Archive

Physicians need to understand comorbidities to better help cancer patients

Findings from a new cancer study may seem obvious — a patient's overall health is a critical factor in assessing prognosis. But the study's authors say data about patients' non-cancer ailments, called comorbidities, are not currently incorporated into cancer statistics.

Nitto Denko announces acquisition of Avecia Biotechnology

Japan's leading diversified materials manufacturer, Nitto Denko Corporation, today announced that it has acquired Avecia Biotechnology, Inc. through Nitto Americas, Inc., a wholly owned subsidiary in Teaneck, New Jersey.

Findings could bring hope for novel therapeutic strategies against malaria

The Plasmodium parasite, which transmits malaria to humans through infected mosquitos, triggers changes in human genes that alter the body's adaptive immune response to malarial infections, according to a team of researchers at NYU Abu Dhabi (NYUAD).

Cipher Pharmaceuticals' enrollment milestone in CIP-ISOTRETINOIN study triggers $2.0M milestone payment

Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.

GSK will ensure experimental malaria vaccine is affordable, CEO says

GlaxoSmithKline CEO Andrew Witty said Wednesday the company would ensure that if an experimental malaria vaccine works, it would be priced reasonably, Reuters reports. "The vaccine, called Mosquirix [or RTS,S] and the first malaria shot to make it to final-stage trials, is creating a buzz ahead of a conference of 1,500 malaria experts in Nairobi next week," writes Reuters.

Read more Medical News

› Verified 5 days ago